NO973312L - Racemiseringsprosess for fremstilling av Levobupivacaine og beslektede piperidinkarboksanilid-bedövelsesmidler - Google Patents
Racemiseringsprosess for fremstilling av Levobupivacaine og beslektede piperidinkarboksanilid-bedövelsesmidlerInfo
- Publication number
- NO973312L NO973312L NO973312A NO973312A NO973312L NO 973312 L NO973312 L NO 973312L NO 973312 A NO973312 A NO 973312A NO 973312 A NO973312 A NO 973312A NO 973312 L NO973312 L NO 973312L
- Authority
- NO
- Norway
- Prior art keywords
- levobupivacaine
- anesthetics
- preparation
- carboxanilide
- racemization process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Beans For Foods Or Fodder (AREA)
- Rolling Contact Bearings (AREA)
- Optical Head (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9501071.6A GB9501071D0 (en) | 1995-01-18 | 1995-01-18 | Racemisation |
| PCT/GB1996/000067 WO1996022281A1 (en) | 1995-01-18 | 1996-01-12 | Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO973312D0 NO973312D0 (no) | 1997-07-17 |
| NO973312L true NO973312L (no) | 1997-07-17 |
| NO308843B1 NO308843B1 (no) | 2000-11-06 |
Family
ID=10768271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973312A NO308843B1 (no) | 1995-01-18 | 1997-07-17 | Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0804417B1 (no) |
| JP (1) | JP4015696B2 (no) |
| KR (1) | KR100404390B1 (no) |
| CN (1) | CN1172912C (no) |
| AT (1) | ATE242214T1 (no) |
| AU (1) | AU701221B2 (no) |
| BR (1) | BR9606821A (no) |
| CA (1) | CA2208522C (no) |
| DE (1) | DE69628540T2 (no) |
| DK (1) | DK0804417T3 (no) |
| ES (1) | ES2201166T3 (no) |
| FI (1) | FI117437B (no) |
| GB (1) | GB9501071D0 (no) |
| HU (1) | HU227426B1 (no) |
| MX (1) | MX9705428A (no) |
| NO (1) | NO308843B1 (no) |
| PL (1) | PL184091B1 (no) |
| PT (1) | PT804417E (no) |
| WO (1) | WO1996022281A1 (no) |
| ZA (1) | ZA96403B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0002246A (pt) | 2000-04-06 | 2003-04-15 | Cristalia Prod Quimicos Farm | Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| ATE482695T1 (de) | 2002-12-13 | 2010-10-15 | Durect Corp | Orale darreichungsform mit flüssigen hochviskosen trägersystemen |
| LT2767292T (lt) | 2004-09-17 | 2016-12-12 | Durect Corporation | Palaikomosios vietinės anestezijos mišinys su saib |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| DK2117521T3 (da) | 2006-11-03 | 2012-09-03 | Durect Corp | Transdermale indgivelsessystemer omfattende bupivacain |
| AU2008335809A1 (en) | 2007-12-06 | 2009-06-18 | Durect Corporation | Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| CN102093284B (zh) * | 2010-12-29 | 2013-05-08 | 宜昌人福药业有限责任公司 | 富集哌啶-2-甲酰苯胺类旋光化合物的方法 |
| TW201521769A (zh) | 2013-03-15 | 2015-06-16 | Durect Corp | 具有流變改質劑以減少溶解變異性之組成物 |
| CN106187864B (zh) * | 2016-07-11 | 2018-11-23 | 江苏天和制药有限公司 | 一种由盐酸布比卡因制备高纯度布比卡因碱的方法 |
| BR112022013784A2 (pt) | 2020-01-13 | 2022-10-11 | Durect Corp | Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados |
| WO2023158722A2 (en) * | 2022-02-16 | 2023-08-24 | Teva Pharmaceuticals International Gmbh | Processes for preparation of avacopan and intermediates thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2301498A1 (fr) * | 1975-02-20 | 1976-09-17 | Maggioni & C Spa | Methode pour la racemisation d'une lysine optiquement active |
-
1995
- 1995-01-18 GB GBGB9501071.6A patent/GB9501071D0/en active Pending
-
1996
- 1996-01-12 PT PT96900349T patent/PT804417E/pt unknown
- 1996-01-12 DK DK96900349T patent/DK0804417T3/da active
- 1996-01-12 CA CA002208522A patent/CA2208522C/en not_active Expired - Lifetime
- 1996-01-12 MX MX9705428A patent/MX9705428A/es unknown
- 1996-01-12 AT AT96900349T patent/ATE242214T1/de active
- 1996-01-12 EP EP96900349A patent/EP0804417B1/en not_active Expired - Lifetime
- 1996-01-12 ES ES96900349T patent/ES2201166T3/es not_active Expired - Lifetime
- 1996-01-12 BR BR9606821A patent/BR9606821A/pt unknown
- 1996-01-12 DE DE69628540T patent/DE69628540T2/de not_active Expired - Lifetime
- 1996-01-12 AU AU43948/96A patent/AU701221B2/en not_active Expired
- 1996-01-12 CN CNB961915242A patent/CN1172912C/zh not_active Expired - Lifetime
- 1996-01-12 WO PCT/GB1996/000067 patent/WO1996022281A1/en active IP Right Grant
- 1996-01-12 JP JP52210296A patent/JP4015696B2/ja not_active Expired - Lifetime
- 1996-01-12 KR KR1019970704822A patent/KR100404390B1/ko not_active IP Right Cessation
- 1996-01-12 HU HU9901418A patent/HU227426B1/hu unknown
- 1996-01-12 PL PL96321378A patent/PL184091B1/pl unknown
- 1996-01-18 ZA ZA96403A patent/ZA96403B/xx unknown
-
1997
- 1997-07-17 FI FI973040A patent/FI117437B/fi not_active IP Right Cessation
- 1997-07-17 NO NO973312A patent/NO308843B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69628540D1 (de) | 2003-07-10 |
| JPH11501905A (ja) | 1999-02-16 |
| NO973312D0 (no) | 1997-07-17 |
| MX9705428A (es) | 1997-11-29 |
| ATE242214T1 (de) | 2003-06-15 |
| KR100404390B1 (ko) | 2004-01-31 |
| HUP9901418A3 (en) | 2001-01-29 |
| AU4394896A (en) | 1996-08-07 |
| KR19980701432A (ko) | 1998-05-15 |
| NO308843B1 (no) | 2000-11-06 |
| CN1168134A (zh) | 1997-12-17 |
| PT804417E (pt) | 2003-09-30 |
| BR9606821A (pt) | 1997-12-23 |
| HUP9901418A2 (hu) | 1999-08-30 |
| EP0804417A1 (en) | 1997-11-05 |
| GB9501071D0 (en) | 1995-03-08 |
| DE69628540T2 (de) | 2004-01-08 |
| FI973040A0 (fi) | 1997-07-17 |
| EP0804417B1 (en) | 2003-06-04 |
| CN1172912C (zh) | 2004-10-27 |
| DK0804417T3 (da) | 2003-10-06 |
| CA2208522A1 (en) | 1996-07-25 |
| PL321378A1 (en) | 1997-12-08 |
| FI117437B (fi) | 2006-10-13 |
| HU227426B1 (en) | 2011-05-30 |
| WO1996022281A1 (en) | 1996-07-25 |
| ZA96403B (en) | 1997-01-20 |
| AU701221B2 (en) | 1999-01-21 |
| FI973040A (fi) | 1997-07-17 |
| CA2208522C (en) | 2007-03-13 |
| PL184091B1 (pl) | 2002-08-30 |
| JP4015696B2 (ja) | 2007-11-28 |
| ES2201166T3 (es) | 2004-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO308843B1 (no) | Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler | |
| DE69629670D1 (de) | Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen | |
| AU3738597A (en) | Molecular model for vla-4 inhibitors | |
| RU93057733A (ru) | Способ стереоселективного получения замещенных пиперидинов | |
| NO314725B1 (no) | N-substituerte indol-3-glyoksylamider, deres fremstilling, anvendelse for fremstilling av medikamenter, legemidler inneholdende disse samt enfremgangsmåtefor fremstilling av et legemiddel | |
| DE69535592D1 (de) | Verbesserung der effektivität von arzneimitteln duren deuterierung | |
| UA32566C2 (uk) | Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану | |
| DE69531624D1 (de) | Verfahren zur herstellung von levobupivacaine und analoge | |
| BR9809389A (pt) | Tratamento de distúrbios do sistema nervoso central com modulados de receptores de estrogênio seletivos | |
| YU48698A (sh) | Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze | |
| NO982712D0 (no) | FremgangsmÕter og mellomprodukter for fremstilling av 1-benzyl-4-((5,6-dimetoksy-1-indanon)-2-yl)metylpiperidin | |
| ATE214695T1 (de) | Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen | |
| DE69710051D1 (de) | Auflösungsverfahren von threo-methylphenidate | |
| DE69624825D1 (de) | Eintopfverfahren zur herstellung von 2-oxazolidinonderivate | |
| NO981444D0 (no) | Akustisk transduser, hydrofon med slik transduser og fremgangsmåte for fremstilling av hydrofonen | |
| DE59604829D1 (de) | Kontinuierliches Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin | |
| NO304828B1 (no) | Nye cykliske aminosyrer og derivater derav, fremgangsmÕte til deres fremstilling samt mellomprodukt | |
| DE59606057D1 (de) | Verfahren zur herstellung von dihydroxypyrimidin-derivaten | |
| DK0914605T3 (da) | Molekylemodel for VLA-4-inhibitorer | |
| DK1246790T3 (da) | Substituerede 1- og 2-naphthol-Mannichbaser | |
| NO20023386D0 (no) | Pseudopolymorf av (-)-cis-2-(2-klorfenyl)-5,7-dihydroksy-8(4R- (3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on | |
| ATE212969T1 (de) | Verfahren zur herstellung von 2-halogenindan-1- onen | |
| DE69627184D1 (de) | 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften | |
| AU7377296A (en) | Method for treating hepatitis virus infection | |
| ATE256689T1 (de) | Verfahren zur herstellung von ascorbinsaüre-2- monophosphat salz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |